Epistasis contributes to the genetic buffering of plasma HDL cholesterol in mice

Physiological Genomics

Volumn 42 A, Issue 4, 2010, Pages 228-234

  Li, Renhua H ^a,b   Churchill, Gary A ^a  

^a JACKSON LABORATORY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Structural equation model

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ARL4D GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; FAT INTAKE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC EPISTASIS; HEREDITY; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADP-RIBOSYLATION FACTORS; ANIMALS; CHOLESTEROL, HDL; CROSSES, GENETIC; DIETARY FATS; EPISTASIS, GENETIC; FEMALE; LIPOPROTEINS, HDL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; SPECIES SPECIFICITY;

MUS;

EID: 78649726447     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00044.2010     Document Type: Article

References (42)

1. Alon U, Surette MG, Barkai N, Leibler S. Robustness in bacterial chemotaxis. Nature 397: 168-171, 1999.
2. Arnett DK, Baird AE, Barkley RA, Basson CT, Boerwinkle E, Ganesh SK, Herrington DM, Hong Y, Jaquish C, McDermott DA, O'Donnell CJ. Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115: 2878-2901, 2007.
3. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890, 2003. (Pubitemid 36582406)
4. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.
5. Cheverud JM, Vaughn TT, Pletscher LS, Peripato AC, Adams ES, Erikson CF, King-Ellison KJ. Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice. Mamm Genome 12: 3-12, 2001.
6. Churchill GA, Doerge RW. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971, 1994.
7. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354: 1264-1272, 2006.
8. Colinayo VV, Qiao JH, Wang X, Krass KL, Schadt E, Lusis AJ, Drake TA. Genetic loci for diet-induced atherosclerotic lesions and plasma lipids in mice. Mamm Genome 14: 464-471, 2003.
9. Crawford DC, Nord AS, Badzioch MD, Ranchalis J, McKinstry LA, Ahearn M, Bertucci C, Shephard C, Wong M, Rieder MJ, Schellenberg GD, Nickerson DA, Heagerty PJ, Wijsman EM, Jarvik GP. A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk. J Lipid Res 49: 588-596, 2008.
10. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, Nadeau JH. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet 11: 446-450.
11. Fox J. Structural equation modeling with the sem package in R. Struct Eq Model 13: 465-486, 2006. (Pubitemid 44126430)
12. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis, 2nd ed. Boca Raton, FL: Chapman and Hall/CRC, 2004.
13. Haley CS, Knott SA. A simple regression method for mapping quantitative trait loci in line crosses using flanking markers. Heredity 69: 315-324, 1992.
14. Hansen TF. The evolution of genetic architecture. Annu Rev Ecol Evol Syst 37: 123-157, 2006.
15. Jasnos L, Korona R. Epistatic buffering of fitness loss in yeast double deletion strains. Nat Genet 39: 550-554, 2007. (Pubitemid 46514769)
16. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65, 2009.
17. Lehmann EL, D'Abrera HJM. Nonparametrics: Statistical Methods Based on Ranks. New York: McGraw-Hill, 1988.
18. Li R, Tsaih SW, Shockley K, Stylianou IM, Wergedal J, Paigen B, Churchill GA. Structural model analysis of multiple quantitative traits. PLoS Genet 2: e114, 2006.
19. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
20. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133-140, 1994. (Pubitemid 124004418)
21. Nishina PM, Lowe S, Verstuyft J, Naggert JK, Kuypers FA, Paigen B. Effects of dietary fats from animal and plant sources on diet-induced fatty streak lesions in C57BL/6J mice. J Lipid Res 34: 1413-1422, 1993. (Pubitemid 23230318)
22. Ordovas JM, Corella D, Kaput J. Nutrient-gene interactions in lipoprotein metabolism - an overview. Forum Nutr 60: 102-109, 2007.
23. Paigen B. Genetics of responsiveness to high-fat and high-cholesterol diets in the mouse. Am J Clin Nutr 62: 458S-462S, 1995.
24. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57: 65-73, 1985.
25. Paigen K. A miracle enough: the power of mice. Nat Med 1: 215-220, 1995.
26. Pinheiro J, Bates D, DebRoy S, Sarkar D, team tRC. nlme: Linear and Nonlinear Mixed Effects Models (R package version 3.1-93), 2009.
27. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353, 1992.
28. Rader DJ. Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 116: 3090-3100, 2006.
29. Rice SH. A general population genetic theory for the evolution of developmental interactions. Proc Natl Acad Sci USA 99: 15518-15523, 2002.
30. Rutherford SL. From genotype to phenotype: buffering mechanisms and the storage of genetic information. Bioessays 22: 1095-1105, 2000.
31. Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, Guhathakurta D, Sieberts SK, Monks S, Reitman M, Zhang C, Lum PY, Leonardson A, Thieringer R, Metzger JM, Yang L, Castle J, Zhu H, Kash SF, Drake TA, Sachs A, Lusis AJ. An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 37: 710-717, 2005.
32. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB, Friend SH. Genetics of gene expression surveyed in maize, mouse and man. Nature 422: 297-302, 2003.
33. Schwarz GE. Estimating the dimension of a model. Annal Stat 6: 461-464, 1978.
34. Shipley B. Cause and Correlation in Biology: A User's Guide to Path Analysis, Structural Equations, and Causal Inference, Cambridge: Cambridge University Press, 2000.
35. Shockley KR, Witmer D, Burgess-Herbert SL, Paigen B, Churchill GA. Effects of atherogenic diet on hepatic gene expression across mouse strains. Physiol Genomics 39: 172-182, 2009.
36. Storey JD, Tibshirani R. Statistical methods for identifying differentially expressed genes in DNA microarrays. Meth Mol 224: 149-157, 2003.
37. Su Z, Ishimori N, Chen Y, Leiter EH, Churchill GA, Paigen B, Stylianou IM. Four additional mouse crosses improve the lipid QTL landscape and identify Lipg as a QTL gene. J Lipid Res 50: 2083-2094, 2009.
38. Svenson KL, Smith RV, Magnani PA, Suetin HR, Paigen B, Naggert JK, Li R, Churchill GA, Peters LL. Multiple trait measurements in 43 inbred mouse strains capture the phenotypic diversity characteristic of human populations. J Appl Physiol 102: 2369-2378, 2007. (Pubitemid 47080772)
39. Taylor BA, Wnek C, Kotlus BS, Roemer N, MacTaggart T, Phillips SJ. Genotyping new BXD recombinant inbred mouse strains and comparison of BXD and consensus maps. Mamm Genome 10: 335-348, 1999.
40. Wagner A. Robustness and Evoluability in Living Systems. Princeton, NJ: Princeton University Press, 2005.
41. Warden CH, Yi N, Fisler J. Epistasis among genes is a universal phenomenon in obesity: evidence from rodent models. Nutrition 20: 74-77, 2004.
42. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40: 161-169, 2008.